ContributorsPublishersAdvertisers

Dr. Bekaii-Saab on the Updated Results of the KRYSTAL-1 Trial in KRAS G12C+ GI Cancers

onclive.com
 2022-01-22

Tanios S. Bekaii-Saab, MD, FACP, discusses the updated results of the ongoing phase 1/2 KRYSTAL-1 trial in KRAS G12C-mutated gastrointestinal cancers, including pancreatic ductal adenocarcinoma. Tanios S. Bekaii-Saab, MD, FACP, professor of medicine, consultant, medical oncologist, leader, Gastrointestinal Cancer Program, medical director, Cancer Clinical Research Office, vice chair and...

www.onclive.com

Comments / 0

Comments / 0